Prenexus Health produces certified-organic XOS (xylo-oligosaccharide) branded as PreneXOS™, a low-dose prebiotic ingredient that feeds beneficial probiotic bacteria in the gut microbiome in as little as one gram per day. The company uses a novel process to produce XOS from U.S.-grown organic sugar cane at its Gilbert, Arizona manufacturing facility. Proceeds from its recent financing will be used to significantly expand production capacity at that plant. Prenexus positions PreneXOS for use across supplement, food, beverage, and companion animal applications due to the ingredient's stability and low effective dose. The company emphasizes scientific development and clinical research as part of its product strategy. The announcement frames the financing as expansion capital to meet unprecedented demand for the ingredient.

Total raised

$15M

Funding rounds

1

Latest round

Series B

Latest activity

Jul 2021